Despite the rapid innovation of machine learning, correct protocols to ensure compliance and trustworthiness must be considered.
Michelle Marlborough
Advertisement
Chief product officer, AiCure, LLC
Articles by Michelle Marlborough
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Boehringer Ingelheim Expands Immunology Pipeline With Preclinical Antibody Licensing Deal
2
Marty Makary Out as FDA Commissioner: Report
3
The Insight Gap: Biopharma’s Hidden Risk in the Race Against the Patent Cliff
4
From Consulting to Venture Capital: A Q&A with Gibb Witham, President of Hack The Box
5